Iceland vs Mus: New cases tested for RR-/MDR-TB (%)

Iceland
100.0%
in 2024
Mus
100.0%
in 2024
Iceland rank
1st
Mus rank
1st

New cases tested for RR-/MDR-TB (%) over time

  • Iceland
  • Mus
020406080100200520142024

How they compare

Iceland currently reports 100.0% against 100.0% in Mus, a difference of 0.0%.

Across all 17 years both countries report, Mus has been ahead every year.

Iceland ranks 1st and Mus ranks 1st of 192 countries.

Mus has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Iceland Mus Difference Ahead
2000s 100.0% 100.0% 0.0% —
2010s 92.2% 100.0% 7.8% Mus
2020s 50.0% 100.0% 50.0% Mus

Averages of every year both report within each decade.

Frequently asked questions

Which has higher new cases tested for rr-/mdr-tb, Iceland or Mus?
Iceland, at 100.0% against 100.0% in Mus as of 2024.
What is the difference in new cases tested for rr-/mdr-tb between Iceland and Mus?
0.0%, with Iceland ahead.
How many years of comparable data are there for Iceland and Mus?
17 years are reported by both, from 2005 to 2024.
How do Iceland and Mus rank globally for new cases tested for rr-/mdr-tb?
Iceland ranks 1st and Mus ranks 1st of 192 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Iceland vs Mus: New cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 07 October 2026, from https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/iceland/mus-2/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/iceland/mus-2/">Iceland vs Mus: New cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
New cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
205 places, 3,388 data points, 2005–2024
Last refreshed